Fulton Bank’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-2,628
Closed -$315K 422
2016
Q4
$315K Sell
2,628
-130
-5% -$14.4K 0.03% 330
2016
Q3
$310K Buy
2,758
+363
+15% +$41.8K 0.03% 334
2016
Q2
$297K Sell
2,395
-166
-6% -$20K 0.03% 324
2016
Q1
$288K Sell
2,561
-3,119
-55% -$324K 0.03% 325
2015
Q4
$618K Sell
5,680
-4,057
-42% -$464K 0.06% 190
2015
Q3
$972K Sell
9,737
-807
-8% -$87.8K 0.11% 146
2015
Q2
$1.2M Buy
10,544
+895
+9% +$109K 0.12% 136
2015
Q1
$1.01M Buy
9,649
+641
+7% +$68.3K 0.11% 153
2014
Q4
$1.08M Buy
+9,008
New +$1.18M 0.12% 135

Other funds holding CLB

Fulton Bank's CLB Position: Q1 2017 in Review

Fulton Bank sold out of Core Laboratories (CLB) in Q1 2017, closing a stake of 2,628 shares — an estimated $315K sold.

Fulton Bank first reported a position in CLB in Q4 2014 and held it in 9 quarters. The position peaked at $1.2M in Q2 2015. 360 funds tracked by Wall St. Rank hold CLB as of Q1 2017.

  • Fulton Bank reported no remaining Core Laboratories position as of Q1 2017 after selling out during the quarter.
  • Fulton Bank sold 2,628 Core Laboratories shares in Q1 2017, an estimated $315K.
  • Fulton Bank first reported a position in Core Laboratories in Q4 2014 and held it in 9 quarters.
  • Fulton Bank's Core Laboratories position peaked at $1.2M in Q2 2015.
  • 360 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2017.

Based on Fulton Bank's 13F filing for Q1 2017, filed 6 Apr 2017.